Back
Polen Capital Emerging Markets ex-China Growth ETF Vs. Collegium Pharmaceutical Industry Stock Comparison
Sell
4
PCEM
Polen Capital Emerging Markets ex-China Growth ETF
Last Price:
$10.15
Seasonality Move:
--
Sell
45
COLL
Collegium Pharmaceutical
Last Price:
$33.33
Seasonality Move:
-1.63%
Sell
4
Polen Capital Emerging Markets ex-China Growth ETF (PCEM)
is a Sell
Is Polen Capital Emerging Markets ex-China Growth ETF a Buy, Sell or Hold?
-
The current Polen Capital Emerging Markets ex-China Growth ETF [PCEM] share price is $10.15. The Score for PCEM is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
-
PCEM is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
Collegium Pharmaceutical (COLL)
is a Sell
Is Collegium Pharmaceutical a Buy, Sell or Hold?
-
The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PCEM Stock Price Chart
What is Polen Capital Emerging Markets ex-China Growth ETF's stock price today?
-
The Polen Capital Emerging Markets ex-China Growth ETF share price today is $10.15The current trend is moderately bearish and PCEM is experiencing slight buying pressure.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $33.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.
PCEM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 42 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.16 - 10.3) | Sell |
| Bollinger Bands (100): | ( - ) | Buy |
COLL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 66.05 | Buy |
| Chaikin Money Flow: | 1007158 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.9 - 30.94) | Buy |
| Bollinger Bands (100): | (30.52 - 37.92) | Sell |
PCEM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.17 | Sell |
| 20-day SMA: | 10.23 | Sell |
| 50-day SMA: | 10.25 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 10.17 | Sell |
| 20-day EMA: | 10.2 | Sell |
| 50-day EMA: | 9.81 | Buy |
| 200-day EMA: | 5.62 | Buy |
COLL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.45 | Buy |
| 20-day SMA: | 29.79 | Buy |
| 50-day SMA: | 30.91 | Buy |
| 200-day SMA: | 34.47 | Sell |
| 8-day EMA: | 30.02 | Buy |
| 20-day EMA: | 29.94 | Buy |
| 50-day EMA: | 31.21 | Buy |
| 200-day EMA: | 32.94 | Buy |
Polen Capital Emerging Markets ex-China Growth ETF Earnings Growth & PCEM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.
Polen Capital Emerging Markets ex-China Growth ETF Technical Analysis
| Dec 19 | Dec 20 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Jan 2 | Jan 3 | Jan 6 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 24 | 26 | 27 | 30 | 02 | 03 | 06 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Collegium Pharmaceutical Technical Analysis
| Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||